After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, ENOV falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Enovis Corp is $1.75B. A total of 0.71 million shares were traded on the day, compared to an average of 907.06K shares.
In the most recent transaction, McDonald Damien bought 6,457 shares of ENOV for 30.97 per share on Sep 11 ’25. After the transaction, the Chief Executive Officer now owns 102,753 company shares. In a previous transaction on Aug 22 ’25, Tandy Bradley J bought 3,200 shares at 31.41 per share. ENOV shares that SVP and Chief Legal Officer owns now total 43,515.
Among the insiders who bought shares, BERRY PHILLIP BENJAMIN (BEN) acquired of 2,500 shares on Aug 20 ’25 at a per-share price of $29.71. This resulted in the SVP, Chief Financial Officer holding 116,729 shares of ENOV after the transaction. In another insider transaction, PRYOR DANIEL A bought 10,000 shares at $28.90 per share on Aug 13 ’25. Company shares held by the EVP, Strategy & Business Dev. now total 161,115.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ENOV has a high of $49.83 and a low of $25.47.
As of this writing, ENOV has an earnings estimate of $0.65 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $0.67 per share and a lower estimate of $0.61. The company reported an EPS of $0.73 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ENOV’s latest balance sheet shows that the firm has $680.25M in Cash & Short Term Investments as of fiscal 2021. There were $2.16B in debt and $1.02B in liabilities at the time. Its Book Value Per Share was $45.11, while its Total Shareholder’s Equity was $4.66B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ENOV is Buy with a score of 4.55.
